Publication:
Esmolol Administration for the Treatment of Refractory Ventricular Fibrillation

Simple item page
dc.contributor.authorKaraaslan, KAZIM
dc.contributor.authorUMUTOGLU, Tarik
dc.contributor.authorTOPUZ, Ufuk
dc.contributor.authorAy, YASİN
dc.contributor.institutionauthorKARAASLAN, KAZıM
dc.contributor.institutionauthorAY, YASİN
dc.date.accessioned2019-10-05T15:06:51Z
dc.date.available2019-10-05T15:06:51Z
dc.date.issued2016-12-01
dc.description.abstractVentricular fibrillation (VF) after releasing an aortic cross clamp in patients undergoing open heart surgery procedures is not rare. Ischemiareperfusion injury after release of the aortic clamp, increased adrenergic tone, and insufficient protection of the myocardium are the possible causes. Amiodarone, lidocaine, and beta blockers have been added to the cardioplegia solutions as a preventive measure for reperfusion VF. We report a case of life-threatening, shock-resistant VF during the weaning period of a cardiopulmonary bypass (CPB) in a 61-yearold male who underwent a mitral valve repair surgery for mitral valve regurgitation. After several defibrillation attempts, refractory VF was turned to normal sinus rhythm shortly after ultra-short acting, beta blocking agent esmolol administration. CPB was terminated successfully following this. In conclusion, VF is still a major problem for clinicians and the treatment of refractory VF is not well defined. In contrast with the absence of the sufficient randomized controlled human studies, theoretically beta blockers could be a choice alternative for shock refractory VF.
dc.identifier10.1017/s0022215114000681
dc.identifier.citationKaraaslan K., UMUTOGLU T., TOPUZ U., Ay Y., -Esmolol Administration for the Treatment of Refractory Ventricular Fibrillation-, BEZMIALEM SCIENCE, cilt.4, ss.131-133, 2016
dc.identifier.doi10.14235/bs.2016.570
dc.identifier.urihttps://hdl.handle.net/20.500.12645/5493
dc.identifier.wosWOS:000390866000010
dc.language.isoen
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEsmolol
dc.subjectRefractory
dc.subjectschock resistant
dc.subjectbeta blocker
dc.subjectVF
dc.titleEsmolol Administration for the Treatment of Refractory Ventricular Fibrillation
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameJOURNAL OF LARYNGOLOGY AND OTOLOGY
local.avesis.id874931c2-4dc2-4070-82b0-c6c73f2700a5
local.avesis.response5363
local.publication.isinternational1
relation.isAuthorOfPublication22f7cf54-71fa-4016-96a3-bedae54c1b8f
relation.isAuthorOfPublicationb48faa1a-7374-4ccb-a4f6-1bbe8751e404
relation.isAuthorOfPublication.latestForDiscoveryb48faa1a-7374-4ccb-a4f6-1bbe8751e404
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Esmolol Administration for the Treatment of Refractory Ventricular Fibrillation.pdf
Size:
99.4 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Yayınlar - Eserler
Bezmialem Science Koleksiyonu